LL

Leiv Lea

Chief Financial Officer

Corvus Pharmaceuticals

Therapeutic Areas

Corvus Pharmaceuticals Pipeline

DrugIndicationPhase
Soquelitinib (CPI-818)Relapsed/Refractory T Cell LymphomasPhase 1/1b